Skip Navigation

JNCI Journal of the National Cancer Institute 2003 95(4):254; doi:10.1093/jnci/95.4.254-a
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 95, No. 4, 254, February 19, 2003
© 2003 Oxford University Press

NEWS

Design of CALGB 9741

The first 10% of the full text of this article appears below.

The CALGB 9741 trial tested both sequential versus concurrent chemotherapy administration and a conventional dosing interval versus a dose-dense . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?